However, a landmark July 2025 study published in the Proceedings of the National Academy of Sciences (PNAS) by Shankar, Davis, Bonilla, et al., revealed a fascinating and complex paradox regarding redox homeostasis in these conditions
The safety of GLP-1RAs and GLP-1/GIP dual agonists during pregnancy constitutes a significant area of concern, especially regarding the management of diabetes and obesity in this population
About this article Cite this article Mannucci, E., Dicembrini, I
Microdosing a More Balanced Way to Feel Better Personalized, low-dose GLP-1 and GIP-based formulations designed to support energy, metabolism, and everyday performance
Furthermore, almost half of the participants were positive for anti-icodec antibodies during the study with the vast majority of these participants also being positive for anti-icodec antibodies cross-reacting to human insulin